VRCI Stock Overview
Verde Science, Inc., a pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Verde Science, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | n/a |
3 Year Change | -99.95% |
5 Year Change | -99.96% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
VRCI | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -0.06% | 2.1% |
1Y | n/a | 23.6% | 30.4% |
Return vs Industry: Insufficient data to determine how VRCI performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how VRCI performed against the US Market.
Price Volatility
VRCI volatility | |
---|---|
VRCI Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VRCI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VRCI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | n/a | Harp Sangha | https://www.verdescienceinc.com |
Verde Science, Inc., a pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions. The company was formerly known as Rango Energy, Inc. and changed its name to Verde Science, Inc. in May 2014. Verde Science, Inc. was founded in 2007 and is based in Dallas, Texas.
Verde Science, Inc. Fundamentals Summary
VRCI fundamental statistics | |
---|---|
Market cap | US$23.00 |
Earnings (TTM) | -US$605.56k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs VRCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VRCI income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$605.56k |
Earnings | -US$605.56k |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did VRCI perform over the long term?
See historical performance and comparison